Patents by Inventor Michael J. Roberts

Michael J. Roberts has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8335775
    Abstract: Techniques are provided for managing file versions. In one technique, versions of directories are created responsive to creation of versions of files descendant from the directories. Directory versions are associated with times. Interfile links are maintained so file versions descendant from a directory version reflect the directory version's time. In another technique, a mechanism is provided for tagging file versions that shouldn't be overwritten. Responsive to a first file version's update, it is determined whether that version is tagged. If so, a second version is stored while retaining the first version. Otherwise, the first version is deleted responsive to the second version's storage. In another technique, responsive to a first file version's change, it is determined whether first criteria are satisfied. If so, a second version is created while retaining the first version, and versions of the file's ancestor files that satisfy second criteria are created.
    Type: Grant
    Filed: May 15, 2000
    Date of Patent: December 18, 2012
    Assignee: Oracle International Corporation
    Inventors: Eric Sedlar, Michael J. Roberts
  • Patent number: 8329876
    Abstract: The invention provides reagents and methods for conjugating a polymer specifically to the ?-amine of a polypeptide. The invention provides monofunctional, bifunctional, and multifunctional PEGs and related polymers having a terminal thioester moiety capable of specifically conjugating to the ?-amine of a polypeptide having a cysteine or histidine residue at the N-terminus. The invention provides reactive thioester-terminated PEG polymers that have suitable reactivity with an N-terminal cysteine or histidine residue of a polypeptide to produce an amide bond between the PEG molecule and the polypeptide.
    Type: Grant
    Filed: October 26, 2011
    Date of Patent: December 11, 2012
    Assignee: Nektar Therapeutics
    Inventors: Michael J. Roberts, Zhihao Fang
  • Publication number: 20120260563
    Abstract: This invention relates to a process for thermochemically transforming biomass or other oxygenated feedstocks into high quality liquid hydrocarbon fuels. In particular, a catalytic hydropyrolysis reactor, containing a deep bed of fluidized catalyst particles is utilized to accept particles of biomass or other oxygenated feedstocks that are significantly smaller than the particles of catalyst in the fluidized bed. The reactor features an insert or other structure disposed within the reactor vessel that inhibits slugging of the bed and thereby minimizes attrition of the catalyst. Within the bed, the biomass feedstock is converted into a vapor-phase product, containing hydrocarbon molecules and other process vapors, and an entrained solid char product, which is separated from the vapor stream after the vapor stream has been exhausted from the top of the reactor.
    Type: Application
    Filed: April 18, 2011
    Publication date: October 18, 2012
    Inventors: Terry L. Marker, Larry G. Felix, Martin B. Linck, Michael J. Roberts
  • Publication number: 20120182989
    Abstract: A system and method of enabling a transparent Ethernet switch are disclosed. According to an aspect, a network switch is disclosed. The network switch can include a plurality of physical ports configured to communicate data via a network. The network switch can further include a memory configured to store a first forwarding database, and a plurality of aggregate zone entries within the first forwarding database. The aggregate zone entries can also include a port identifier of first port of the plurality of physical ports to be used as a transparent port within a first aggregate zone.
    Type: Application
    Filed: March 26, 2012
    Publication date: July 19, 2012
    Applicant: DELL PRODUCTS, LP
    Inventors: Hendrich M. Hernandez, Robert L. Winter, Bruce A. Holmes, Michael J. Roberts
  • Publication number: 20120142692
    Abstract: The present invention provides combinations of active agents, such combinations comprising one or more antifolate compounds. The particularly can include methotrexate and one or more further antifolate compounds. In specific embodiments, the combinations are useful for treating certain conditions, such as rheumatoid arthritis. The invention also provides articles useful to provide the combinations in desirable dosage forms and combinations. The combinations further may be useful in the treatment of further conditions, including abnormal cell proliferation, inflammatory diseases, asthma, and arthritis.
    Type: Application
    Filed: December 7, 2011
    Publication date: June 7, 2012
    Inventors: Michael J. Roberts, Gerry Rowse
  • Patent number: 8165119
    Abstract: A system and method of enabling a transparent Ethernet switch are disclosed. According to an aspect, a network switch is disclosed. The network switch can include a plurality of physical ports configured to communicate data via a network. The network switch can further include a memory configured to store a first forwarding database, and a plurality of aggregate zone entries within the first forwarding database. The aggregate zone entries can also include a port identifier of first port of the plurality of physical ports to be used as a transparent port within a first aggregate zone.
    Type: Grant
    Filed: June 30, 2008
    Date of Patent: April 24, 2012
    Assignee: Dell Products, LP
    Inventors: Hendrich M. Hernandez, Robert L. Winter, Bruce A. Holmes, Michael J. Roberts
  • Publication number: 20120065330
    Abstract: The invention provides reagents and methods for conjugating a polymer specifically to the ?-amine of a polypeptide. The invention provides monofunctional, bifunctional, and multifunctional PEGs and related polymers having a terminal thioester moiety capable of specifically conjugating to the ?-amine of a polypeptide having a cysteine or histidine residue at the N-terminus. The invention provides reactive thioester-terminated PEG polymers that have suitable reactivity with an N-terminal cysteine or histidine residue of a polypeptide to produce an amide bond between the PEG molecule and the polypeptide.
    Type: Application
    Filed: October 26, 2011
    Publication date: March 15, 2012
    Applicant: Nektar Therapeutics
    Inventors: Michael J. Roberts, Zhihao Fang
  • Publication number: 20120010293
    Abstract: The present invention provides pharmaceutical compositions comprising droxidopa alone, or in combination with one or more further active ingredients, for the treatment of conditions, such as mood disorders, sleep disorders, or attention deficit disorders. In certain embodiments, the compositions useful in the methods of the invention comprise droxidopa and a compound selected from the group consisting of DOPA decarboxylase inhibiting compounds, catechol-O-methyltransferase inhibiting compounds, cholinesterase inhibiting compounds, monoamine oxidase inhibiting compounds, norepinephrine reuptake inhibiting compounds, selective serotonin reuptake inhibiting compounds, tricyclic antidepressant compounds, serotonin norepinephrine reuptake inhibiting compounds, norepinephrine dopamine reuptake inhibiting compound, noradrenergic and specific serotonergic antidepressants, and combinations thereof.
    Type: Application
    Filed: September 20, 2011
    Publication date: January 12, 2012
    Inventors: Michael J. Roberts, Simon Pedder
  • Publication number: 20110306808
    Abstract: The present invention addresses the processing of waste and low-value products to produce useful materials in reliable purities and compositions, at acceptable cost, without producing malodorous emissions, and with high energy efficiency. In particular, the invention comprises a multi-stage process that converts various feedstocks such as offal, animal manures, municipal sewage sludge, tires, and plastics, that otherwise have little commercial value, to useful materials including gas, oil, specialty chemicals, and carbon solids. The process subjects the feedstock to heat and pressure, separates out various components, then further applies heat and pressure to one or more of those components. Various materials produced at different points in the process may be recycled and used to play other roles within the process. The invention further comprises an apparatus for performing a multi-stage process of converting waste products into useful materials, and at least one oil product that arises from the process.
    Type: Application
    Filed: August 19, 2011
    Publication date: December 15, 2011
    Applicant: AB-CWT, LLC
    Inventors: Brian S. Appel, Terry N. Adams, Michael J. Roberts, William F. Lange, James H. Freiss, Craig Timothy Einfeldt, Michael Charles Carnesi
  • Patent number: 8071678
    Abstract: The invention provides reagents and methods for conjugating a polymer specifically to the ?-amine of a polypeptide. The invention provides monofunctional, bifunctional, and multifunctional PEGs and related polymers having a terminal thioester moiety capable of specifically conjugating to the ?-amine of a polypeptide having a cysteine or histidine residue at the N-terminus. The invention provides reactive thioester-terminated PEG polymers that have suitable reactivity with an N-terminal cysteine or histidine residue of a polypeptide to produce an amide bond between the PEG molecule and the polypeptide.
    Type: Grant
    Filed: October 11, 2010
    Date of Patent: December 6, 2011
    Assignee: Nektar Therapeutics
    Inventors: Michael J. Roberts, Zhihao Fang
  • Patent number: 8051316
    Abstract: Systems and methods for power management in an information handling system are disclosed. A method may include determining a power requirement of resources configured to receive power from a plurality of power supply units including one or more online power supply units, one or more redundant power supply units, and one or more standby power supply units. The method may also include determining a power capacity of the one or more online power supply units. The method may additionally include determining if the power capacity of the one or more online power supply units exceeds the power requirement of the resources. The method may further include transitioning at least one of the power supply units based on such determining steps.
    Type: Grant
    Filed: June 9, 2008
    Date of Patent: November 1, 2011
    Assignee: Dell Products L.P.
    Inventors: Michael J. Roberts, Ashish Munjal
  • Publication number: 20110259786
    Abstract: The present invention provides methods of treating fibromyalgia or other diseases or conditions causing widespread pain and/or fatigue. In particular, the invention provides pharmaceutical compositions comprising droxidopa alone, or in combination with one or more further active agents, that can be used in the inventive methods. The methods of treatment can comprise treating, preventing, reducing, or eliminating a variety of symptoms recognized as indicative of fibromyalgia, such as chronic pain, allodynia, hyperalgesia, fatigue, sleep disturbance, and depression.
    Type: Application
    Filed: July 1, 2011
    Publication date: October 27, 2011
    Inventors: Michael J. Roberts, Simon Pedder
  • Patent number: 8008285
    Abstract: The present invention provides methods of treating fibromyalgia or other diseases or conditions causing widespread pain and/or fatigue. In particular, the invention provides pharmaceutical compositions comprising droxidopa alone, or in combination with one or more further active agents, that can be used in the inventive methods. The methods of treatment can comprise treating, preventing, reducing, or eliminating a variety of symptoms recognized as indicative of fibromyalgia, such as chronic pain, allodynia, hyperalgesia, fatigue, sleep disturbance, and depression.
    Type: Grant
    Filed: March 7, 2008
    Date of Patent: August 30, 2011
    Assignee: Chelsea Therapeutics, Inc.
    Inventors: Michael J. Roberts, Simon Pedder
  • Patent number: 8003833
    Abstract: The present invention addresses the processing of waste and low-value products to produce useful materials in reliable purities and compositions, at acceptable cost, without producing malodorous emissions, and with high energy efficiency. In particular, the invention comprises a multi-stage process that converts various feedstocks such as offal, animal manures, municipal sewage sludge, tires, and plastics, that otherwise have little commercial value, to useful materials including gas, oil, specialty chemicals, and carbon solids. The process subjects the feedstock to heat and pressure, separates out various components, then further applies heat and pressure to one or more of those components. Various materials produced at different points in the process may be recycled and used to play other roles within the process. The invention further comprises an apparatus for performing a multi-stage process of converting waste products into useful materials, and at least one oil product that arises from the process.
    Type: Grant
    Filed: November 18, 2003
    Date of Patent: August 23, 2011
    Assignee: AB-CWT, LLC
    Inventors: Brian S. Appel, Terry N. Adams, Michael J. Roberts, William F. Lange, James H. Freiss, Craig Timothy Einfeldt, Michael Charles Carnesi
  • Publication number: 20110152276
    Abstract: The present invention is directed to antifolate compounds having the structure wherein: X is CHR9 or NR9; Y1, Y2, and Y3 independently are O or S; V1 and V2 independently are O, S, or NZ; Z is H, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, or alkaryl; R1 and R2 independently are H, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, or alkaryl; R3 is H, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted alkoxy, hydroxyl, or halo; and R4, R5, R6, R7, R8, and R9 independently are H, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, acyl, —C(O)-alkyl, —C(O)-alkenyl, or —C(O)-alkynyl; as well as pharmaceutically acceptable esters, amides, salts, solvates, and prodrugs thereof.
    Type: Application
    Filed: February 25, 2011
    Publication date: June 23, 2011
    Inventors: Michael J. Roberts, Simon Pedder
  • Patent number: 7951812
    Abstract: The present invention is directed to antifolate compounds having the structure wherein: X is CHR9 or NR9; Y1, Y2, and Y3 independently are O or S; V1 and V2 independently are O, S, or NZ; Z is H, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, or alkaryl; R1 and R2 independently are H, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, or alkaryl; R3 is H, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted alkoxy, hydroxyl, or halo; and R4, R5, R6, R7, R8, and R9 independently are H, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, acyl, —C(O)-alkyl, —C(O)-alkenyl, or —C(O)—alkynyl; as well as pharmaceutically acceptable esters, amides, salts, solvates, and prodrugs thereof.
    Type: Grant
    Filed: January 18, 2008
    Date of Patent: May 31, 2011
    Assignee: Chelsea Therapeutics, Inc.
    Inventors: Michael J. Roberts, Simon Pedder
  • Publication number: 20110112126
    Abstract: The present invention is directed to compounds that are specifically structured to provide enzyme inhibition. In specific embodiments, the enzyme inhibiting compounds exhibit antifolate activity. Particularly, the inventive compounds are formed of an antifolate residue that is active in inhibiting one or more of TS, DHFR, GAR, FPGS, and AICAR Tfase. The enzyme inhibiting compounds are useful in a variety of methods of treatment, including treating abnormal cell proliferation and treating inflammation.
    Type: Application
    Filed: November 4, 2010
    Publication date: May 12, 2011
    Inventor: Michael J. Roberts
  • Publication number: 20110081338
    Abstract: The present invention provides compositions and methods for the treatment of disorders of abnormal cell proliferation and/or inflammation, such as psoriasis and inflammatory bowel disease, in a human or other host animals.
    Type: Application
    Filed: October 5, 2010
    Publication date: April 7, 2011
    Inventors: Michael J. Roberts, Simon Pedder
  • Publication number: 20110082149
    Abstract: The present invention provides compositions and methods for the treatment of disorders of abnormal cell proliferation and/or inflammation, such as psoriasis and inflammatory bowel disease, in a human or other host animals.
    Type: Application
    Filed: October 5, 2010
    Publication date: April 7, 2011
    Inventors: Michael J. Roberts, Simon Pedder
  • Publication number: 20110065862
    Abstract: The invention provides reagents and methods for conjugating a polymer specifically to the ?-amine of a polypeptide. The invention provides monofunctional, bifunctional, and multifunctional PEGs and related polymers having a terminal thioester moiety capable of specifically conjugating to the ?-amine of a polypeptide having a cysteine or histidine residue at the N-terminus. The invention provides reactive thioester-terminated PEG polymers that have suitable reactivity with an N-terminal cysteine or histidine residue of a polypeptide to produce an amide bond between the PEG molecule and the polypeptide.
    Type: Application
    Filed: October 11, 2010
    Publication date: March 17, 2011
    Applicant: Nektar Therapeutics
    Inventors: Michael J. Roberts, Zhihao Fang